|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.100 CHF | -0.33% |
|
+11.66% | +52.94% |
| 07-01 | Redcare Continues Its Comeback, Shares Have Easily More Than Doubled Since March | DP |
| 06-28 | More Flexibility on Pharmacy Opening Hours | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 442.8 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 53.12% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 644 | 681.2 | 694.2 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 50.91% | 5.77% | 1.91% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -5.75x | -11x | -20.6x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.41x | 1.42x | 1.64x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.2x | 0.4x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.36x | 0.32x | 0.3x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.53x | 0.5x | 0.47x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -34.4x | 37.2x | 13.6x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -9.72x | -18.6x | -55.6x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -9.13x | -21.4x | -48.3x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -10.9% | -4.66% | -2.07% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.589 | -0.8337 | -0.444 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,220 | 1,371 | 1,466 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -18.72 | 18.32 | 51 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -66.25 | -36.72 | -12.48 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -83.51 | -46.79 | -27.42 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.2 | 238.4 | 251.4 |
| Reference price 2 | 235.500 | 25.560 | 73.750 | 19.980 | 5.950 | 9.130 | 9.130 | 9.130 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 48,496 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.75x | 0.53x | -34.4x | -.--% | 548M | ||
| 15.48x | 0.59x | 9.28x | -.--% | 13.38B | ||
| 19.09x | 0.91x | 14.13x | -.--% | 6.35B | ||
| 15.25x | 0.68x | 7.03x | 2.45% | 5.62B | ||
| 15.97x | 0.97x | 7.25x | 4.04% | 3.31B | ||
| 14.51x | 1.23x | 7.47x | 5.7% | 3.24B | ||
| 12.01x | 0.76x | 5.45x | 3.58% | 3.4B | ||
| 41.1x | - | - | - | 2.67B | ||
| 12.39x | 0.5x | 3.95x | 5.58% | 2.71B | ||
| Average | 15.56x | 0.77x | 2.52x | 2.67% | 4.58B | |
| Weighted average by Cap. | 16.86x | 0.75x | 8.09x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
















